Fintech startup Pomelo has raised $40m in a funding round led by Latin American venture capital fund Kaszek. Pomelo aims to enhance payment technology in Latin American markets through its card business modernisation platform. The funds will allow Pomelo to continue investing in technology and double the size of its business in 2024. Pomelo’s technology allows companies in multiple countries to offer prepaid, debit and credit cards to customers through a single integration. The company has a presence in Argentina, Brazil, Chile, Colombia, Mexico and Peru.
Revolutionizing LatAm Payments: Fintech Pomelo Gains $40M Boost
Latest from Blog
Lessons for Global Venture Capitalists from Europe’s Tech Reset
TLDR: The tech market correction in Europe offers lessons for global venture capitalists. Strategies for navigating challenges include building resilient relationships, demonstrating value proposition, and adaptability to setbacks. The article discusses the
Accel Partners Funds e6data: Revolutionizing Retail Tech with Data Intelligence
TLDR: e6data, a data intelligence startup, secured a $10 million Series A funding round led by Accel Partners. The company aims to help businesses reduce costs associated with analyzing their data and
Boosting Start-Up Investment: Financial Sector Aims for $12 Billion
TLDR: The financial sector plans to invest around twelve billion euros by 2030 to support start-ups. The initiative aims to improve structures and provide more venture capital for young companies. Representatives from
Top 10 Startups Set to Battle for $500k at Venture Atlanta 2024 Startup Showdown
TLDR: Ten startups have been selected to pitch for a $500,000 investment prize at Venture Atlanta 2024’s Startup Showcase Live event. The selected startups cover a wide range of industries, from AgTech
HEIST Investments: Leading $18M Investment in Secretome Therapeutics
TLDR: Dallas-based HEST Investments led a $1.8M SPV investment in Baltimore-based Secretome Therapeutics. Secretome Therapeutics is developing innovative therapies using naturally occurring molecules that promote healing and regeneration. Dallas-based venture capital family